Evidence map›Paper›PMID 36906610›Full record

ArticleNature communications2023

Hypomorphic Brca2 and Rad51c double mutant mice display Fanconi anemia, cancer and polygenic replication stress.

Karl-Heinz Tomaszowski, Sunetra Roy, Carolina Guerrero, Poojan Shukla, Caezaan Keshvani, Yue Chen, Martina Ott, Xiaogang Wu, Jianhua Zhang, Courtney D DiNardo and 2 more

Erratum issuedOpen access · goldFull text read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Karl-Heinz TomaszowskiDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.
Sunetra RoyDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.
Carolina GuerreroDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.ORCID http://orcid.org/0000-0001-6029-4133
Poojan ShuklaDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.
Caezaan KeshvaniDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.
Yue ChenDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.
Martina OttDepartment of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.ORCID http://orcid.org/0000-0003-4397-2590
Xiaogang WuDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.
Jianhua ZhangDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.ORCID http://orcid.org/0000-0001-5412-9860
Courtney D DiNardoDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.ORCID http://orcid.org/0000-0001-9003-0390
Detlev SchindlerInstitut fuer Humangenetik, University of Wuerzburg, Wuerzburg, Germany.ORCID http://orcid.org/0000-0003-2451-8165
Katharina SchlacherDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. kschlacher@mdanderson.org.ORCID http://orcid.org/0000-0001-7226-6391
The University of Texas MD Anderson Cancer Center · USUniversity of Würzburg · DE

Funding

Mechanism of RAD51C fork protection and environmental carcinogenesisR01ES029680 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SCHLACHER, KATHARINA · 2018 to 2022
$1.8M
NIEHS NIH HHS R01 ES029680
6 · The paper itself

Abstract

The prototypic cancer-predisposition disease Fanconi Anemia (FA) is identified by biallelic mutations in any one of twenty-three FANC genes. Puzzlingly, inactivation of one Fanc gene alone in mice fails to faithfully model the pleiotropic human disease without additional external stress. Here we find that FA patients frequently display FANC co-mutations. Combining exemplary homozygous hypomorphic Brca2/Fancd1 and Rad51c/Fanco mutations in mice phenocopies human FA with bone marrow failure, rapid death by cancer, cellular cancer-drug hypersensitivity and severe replication instability. These grave phenotypes contrast the unremarkable phenotypes seen in mice with single gene-function inactivation, revealing an unexpected synergism between Fanc mutations. Beyond FA, breast cancer-genome analysis confirms that polygenic FANC tumor-mutations correlate with lower survival, expanding our understanding of FANC genes beyond an epistatic FA-pathway. Collectively, the data establish a polygenic replication stress concept as a testable principle, whereby co-occurrence of a distinct second gene mutation amplifies and drives endogenous replication stress, genome instability and disease.

Indexed as

Breast NeoplasmsFanconi AnemiaAnimalsBRCA2 ProteinDNA-Binding ProteinsFemaleGenotypeHumansMiceMutationPhenotypeBRCA2 ProteinBRCA2 protein, mouseDNA-Binding ProteinsRAD51C protein, mouse

Identifiers

PMID36906610
PMCPMC10008622
OpenAlexW4323971857

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read51
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.